Clodronate appeared safe, modestly affected breast cancer disease events
A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of distant metastases in postmenopausal ...
Dec 7, 2011
0
0